Do you recommend axillary dissection for women with ER+ breast cancer and low risk Oncotype or Mammaprint if single node positive with only 1-2 SLN removed, to ensure <4 nodes positive?
Answer from: Radiation Oncologist at Academic Institution
No, I see no need to do dissection in this setting. Unless there is clinical or imaging evidence of gross disease, radiation should adequately control microscopic residual disease in the axilla.
Comments
Radiation Oncologist at West Virginia University If the patient qualifies for the eligibility crite...
Radiation Oncologist at Northeast Alabama Regional Medical Center Dr. @Haffty, to Dr. @Pollock's point, why do ...
Radiation Oncologist at Rutgers Robert Wood Johnson Medical School Depending on the age and other factors, I would li...
Answer from: Radiation Oncologist at Academic Institution
With six randomized trials for patients with upfront 1-2 SNLN positive (Z011, AMAROS, SINODAR-ONE, OTOASOR, AATRM, and IBCSG) showing ALND doesn’t improve regional control, DFS or OS but adds to morbidity, ALND for this subset, for the most part, is out. The unanswered question or variability ...
Answer from: Medical Oncologist at Community Practice
I am guessing the intent of the question was to determine the need for chemotherapy in 1-3 positive nodes with a low score and whether inadequate dissection would miss those patients with 4 or more nodes to whom RxPONDER would not apply. I am also going to assume this is a postmenopausal woman since...
Comments
Medical Oncologist at Mercy Medical Center - Maryland Yes, thank you. That is the clinical question. I d...
Medical Oncologist at Private Practice and Digital Health I might push for more nodal clearance in a 3 out o...
Medical Oncologist at Clinical Instructor This recent post-hoc analysis of the SENOMAC trial...
If the patient qualifies for the eligibility crite...
Dr. @Haffty, to Dr. @Pollock's point, why do ...
Depending on the age and other factors, I would li...